Phase 3 Trial of BI 695502 Plus Chemotherapy Versus Bevacizumab Reference Product Plus Chemotherapy in Patients With Advanced Nonsquamous NSCLC

Autor: Kim, Edward S., Balser, Sigrid, Rohr, Klaus B., Lohmann, Ragna, Liedert, Bernd, Schliephake, Dorothee
Zdroj: In JTO Clinical and Research Reports January 2022 3(1)
Databáze: ScienceDirect